Group One Trading
LYRA

Group One Trading’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Group One Trading’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$1.05K – 7580
2023
Q4 		$1.05K Hold
4
– – ﹤0.01% 6982
2023
Q3 		$782 Buy
+4
New +$716 ﹤0.01% 7263

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Group One Trading's LYRA Position: Q1 2024 in Review

Group One Trading sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2024, closing a stake of 4 shares — an estimated $1.05K sold.

Group One Trading first reported a position in LYRA in Q3 2023 and held it in 2 quarters. The position peaked at $1.05K in Q4 2023. 78 funds tracked by Wall St. Rank hold LYRA as of Q1 2024.

  • Group One Trading reported no remaining LYRA THERAPEUTICS INC position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 4 LYRA THERAPEUTICS INC shares in Q1 2024, an estimated $1.05K.
  • Group One Trading first reported a position in LYRA THERAPEUTICS INC in Q3 2023 and held it in 2 quarters.
  • Group One Trading's LYRA THERAPEUTICS INC position peaked at $1.05K in Q4 2023.
  • 78 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.